Avicenna.AI Secures CE Mark for Innovative AI Tools
EU certification granted for advanced algorithms addressing vertebral and cervical spine fractures.
Avicenna.AI, a pioneering company in medical imaging AI, recently celebrated a significant milestone by receiving the CE Mark certification for its ground-breaking AI algorithms, the CINA-VCF Quantix and CINA-CSpine. These tools are designed to enhance the detection and analysis of vertebral compression fractures (VCFs) and cervical spine fractures during CT scans undertaken for unrelated medical reasons.
The CE Mark represents a robust assurance that Avicenna.AI's innovative products meet the rigorous health and safety standards mandated by the European Union. This certification facilitates the deployment of their technologies across the European Economic Area, promoting improved patient outcomes without facing additional regulatory hurdles.
VCFs, often linked to conditions such as osteoporosis, contribute to severe pain and structural deformities, affecting countless individuals. Surprisingly, in the United States alone, around 750,000 adults experience these fractures yearly, with a staggering two-thirds remaining undiagnosed. This lack of identification can lead to a heightened risk of subsequent fractures and further health complications.
The CINA-VCF Quantix is tailor-made for patients aged 50 and above who are having CT scans of the chest or abdomen for other health concerns. This sophisticated tool automatically annotates the vertebrae and assesses the ratios of vertebral height loss in the thoracic and lumbar regions. If it identifies a vertebral height loss ratio exceeding 20% to 25%, which indicates a moderate to severe VCF, it sends alerts to radiologists, fostering timely intervention and improved patient care.
“Osteoporotic vertebral fractures have a substantial impact on an individual's quality of life. Launching CINA-VCF Quantix in Europe signifies a pivotal advancement in preventive healthcare, empowering healthcare providers to address issues before they necessitate more aggressive treatments,” remarked Cyril Di Grandi, co-founder and CEO of Avicenna.AI. “By promoting the early reporting of VCFs, we aim to significantly enhance patient outcomes.”
Cervical spine fractures, typically the result of traumatic events, pose severe challenges, as they can disrupt the spinal cord and potentially lead to neurological issues or paralysis. Therefore, rapid diagnosis and appropriate treatment are crucial for improving recovery prospects and mitigating long-term health risks.
The CINA-CSpine tool actively monitors for signs of acute cervical spine fractures. It promptly notifies radiologists, facilitating quicker diagnoses and timely medical responses.
“The introduction of CINA-CSpine into the European market represents a major leap in trauma care. By shortening the diagnosis timeline, we’re enabling radiologists to identify cervical spine fractures more efficiently — a critical factor when swift action is essential,” commented Di Grandi. “CINA-CSpine operates as a vigilant safety net, significantly boosting diagnostic accuracy and enhancing patient outcomes throughout Europe.”
All Avicenna.AI offerings seamlessly integrate into the workflows utilized by radiologists, ensuring that algorithmic results are automatically triggered and communicated through the platforms currently in use. Alongside these new products, the company also provides a range of AI tools for various conditions including:
- Intracranial hemorrhage (CINA-ICH)
- Large vessel occlusion (CINA-LVO)
- Aortic dissection (CINA-AD)
- Pulmonary embolism (CINA-PE and CINA-iPE)
- Vertical compression fractures (CINA-VCF)
- ASPECT Score for assessing stroke severity (CINA-ASPECTS).
About Avicenna.AI
Founded in 2018, Avicenna.AI is dedicated to delivering advanced healthcare AI solutions that leverage deep learning to effectively detect and quantify severe pathologies from CT imaging. The company was co-founded by Cyril Di Grandi, an accomplished entrepreneur and former founder of Olea Medical, in conjunction with Dr. Peter Chang, an esteemed radiologist and authority in deep learning technologies. Avicenna.AI is on a mission to enhance clinical decision-making and patient outcomes through its AI-integrated radiology services.
Frequently Asked Questions
What products did Avicenna.AI receive CE Mark certification for?
Avicenna.AI secured CE Mark certification for CINA-VCF Quantix and CINA-CSpine, both aimed at improving imaging for spine injuries.
Why are VCFs significant in medical imaging?
VCFs can lead to chronic pain and serious complications but often go undiagnosed, making accurate detection vital for patient care.
How does CINA-VCF Quantix assist healthcare providers?
This AI tool automatically detects vertebral height loss in CT scans, alerting radiologists to potential VCFs for timely intervention.
What is the role of CINA-CSpine in trauma care?
CINA-CSpine flags suspected cervical spine fractures, allowing radiologists to diagnose and act quickly, enhancing patient outcomes.
Who are the founders of Avicenna.AI?
Avicenna.AI was co-founded by Cyril Di Grandi, a successful entrepreneur, and Dr. Peter Chang, a noted radiologist and AI expert.
